JPRN-UMIN000011004
Completed
Phase 1
Haploidentical hematopoietic stem cell transplantation with posttransplant cyclophosphamide in combination with thymoglobulin (RIC version) Phase I - Post-haploSCT CY protocol (RIC version)
ConditionsHematological malignancy
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Hematological malignancy
- Sponsor
- ational Cancer Center Hospital
- Enrollment
- 12
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) severe organ dysfunction (2\) uncontrolled hypertenstion (3\) HIV (4\) uncontrolled active infection (5\) uncontrolled CNS disease (6\) pregnant (7\) uncontrolled mental disorder (8\) allergy to drugs used as conditioning regimen or GVHD prophylaxis (9\) recent high\-dose chemotherapy (10\) patients whom the physician regard as inappropriate for this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Haploidentical hematopoietic stem cell transplantation in combination with posttransplant cyclophosphamide and ATG-thymoglobulin Phase I studyhematological malignancyJPRN-UMIN000009374ational Cancer Center Hospital15
Completed
Phase 2
Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1HIRCT138706061030N2Tehran University of Medical Sciences10
Completed
Not Applicable
Allogeneic hematopoietic stem cell transplantation for elderly patientsJPRN-UMIN000017744nivesity of Tokyo Hospital, Department of Hematology and Oncology50
Completed
Not Applicable
Allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-haploidentical related donor using reduced dose of posttransplantation high-dose cyclophosphamide (PTCy) for poor prognosis or refractory hematological malignancies (OCU16-2)Acute myeloid leukemia(AML) Acute lymphoblastic leukemia(ALL) Acute leukemias of ambiguous lineage Myelodysplastic syndrome(MDS) Chronic myeloid leukemia(CML) Adult T-cell leukemia/lymphoma(ATLL) Malignant lymphoma(ML)JPRN-UMIN000026028Osaka City University33
Recruiting
Phase 2
Allogeneic hematopoietic stem cell transplantation from HLA6/8-4/8 matched related donor for poor prognostic or refractory hematologic malignancy and solid tumor - Ibaraki Children's Hospital phase II studyAcute leukemia, malignant lymphoma, and solid tumorJPRN-UMIN000027010Ibaraki Children's Hospital30